A randomized multicenter open label phase II study to determine the safety and efficacy of induction therapy with imatinib (Glivec, formerly STI571) in comparison with standard induction chemotherapy in elderly (>55 years) patients with Philadelphia chromosome-positive (Ph+ /BCR-ABL+ ) acute lymphoblastic leukemia (ALL) (CSTI571ADE 10)
Annals of Hematology（2003）
关键词
Imatinib, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia, Allogeneic Stem Cell Transplantation, Nonhematologic Toxicity
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要